Adherex, Scynexis to Speed Design of Small Molecule Cadherin Antagonists

Adherex Technologies and Scynexis have signed an agreement under which Scynexis will provide comprehensive medicinal and analytical chemistry services to Adherex with the goal of accelerating and expanding Adherex's small molecule cadherin antagonist development programs.

The agreement provides Adherex with dedicated chemistry resources at Scynexis, including a highly experienced medicinal chemistry team backed by innovative technologies. All proprietary information and data developed pursuant to the agreement will be owned solely by Adherex.